Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Mar;59(3):873-8.
doi: 10.1128/iai.59.3.873-878.1991.

Clinical correlates of in vitro Plasmodium falciparum cytoadherence

Affiliations

Clinical correlates of in vitro Plasmodium falciparum cytoadherence

M Ho et al. Infect Immun. 1991 Mar.

Abstract

To determine whether isolates of Plasmodium falciparum have intrinsically different cytoadherent properties and whether these differences contribute to the clinical severity of human falciparum malaria, we studied the cytoadherence to C32 melanoma cells in vitro of 59 parasite isolates from patients with naturally acquired infections in Thailand. Parasitized erythrocytes adhere to these melanoma cells principally via the glycoprotein CD36, which is also expressed on most vascular endothelium. In vitro cytoadherence was significantly greater for isolates from patients with biochemical evidence of severe malaria. The cytoadherent properties of P. falciparum parasites may thus be a virulence factor in human falciparum malaria. However, there was no correlation between the degree of in vitro cytoadherence and cerebral symptoms, which suggests that other receptors and/or host factors may be important in the adherence of malaria parasites to cerebral vascular endothelium. The cytokines tumor necrosis factor, interleukin-1, and gamma interferon, which have been implicated in the pathogenesis of cerebral malaria and are known to promote intercellular adhesion in other systems, did not enhance the cytoadherence of P. falciparum isolates to C32 melanoma cells.

PubMed Disclaimer

References

    1. N Engl J Med. 1989 Jun 15;320(24):1586-91 - PubMed
    1. Science. 1989 Mar 17;243(4897):1469-71 - PubMed
    1. J Clin Invest. 1989 Sep;84(3):765-72 - PubMed
    1. Nature. 1989 Sep 7;341(6237):57-9 - PubMed
    1. Q J Med. 1989 May;71(265):441-59 - PubMed

Publication types